Efficacy of Virechana and Basti Karma with Shamana therapy in the management of essential hypertension: A comparative study
Journal name: AYU (Journal of Research in Ayurveda)
Original article title: Efficacy of Virechana and Basti Karma with Shamana therapy in the management of essential hypertension: A comparative study
AYU is an internationally recognized quarterly journal dedicated to advancing research in Ayurveda. The journal covers a wide range of topics, including clinical and pharmacological research in Ayurveda's eight branches, herbal remedies, phytochemistry, and ethnomedicine.
Original source:
This page is merely a summary which is automatically generated hence you should visit the source to read the original article which includes the author, publication date, notes and references.
Gyanendra Shukla
Santosh K. Bhatted
Alankruta R. Dave
Vageesha Datta Shukla
AYU (Journal of Research in Ayurveda):
(An International Quarterly Journal of Research in Ayurveda)
Full text available for: Efficacy of Virechana and Basti Karma with Shamana therapy in the management of essential hypertension: A comparative study
Year: 2013 | Doi: 10.4103/0974-8520.115455
Copyright (license): CC BY-NC-SA 4.0
Download the PDF file of the original publication
Summary of article contents:
Considering high prevalence and the need to look for alternative medicine, essential hypertension was screened in light of Vata�Pitta Pradhana Rakta Pradoshaja Vikara as mentioned by Acharya Charaka. Comparing the etiological factors, symptomatology, and complications with Rakta Pradoshaja Vikara with that of essential hypertension, a striking similarity was revealed. To prove the practical approach of management of Vata–Pitta Pradhana Rakta Pradoshaja Vikara, a randomized open clinical trial on 33 uncomplicated subjects of essential hypertension was conducted. The subjects were allotted in two groups, viz. (Group A) Virechana group having 16 cases who underwent Virechana Karma by Trivrita, Aragvadha, Eranda Taila, and Draksha Kwatha as Sahapana; and (Group B) Basti group consisting of 17 cases who were administered Dashmoola Kala Basti in which Niruha with Dashmoola Kwatha and Anuvasana with Dashmoola Taila was done. Patients of both the groups were followed by Shamana Chikitsa (Arjunadi Ghanavati). The overall effect of the therapies on systolic and diastolic blood pressure showed that Virechana proved better relief (43.75%) as compared to Basti (29.41%). The response was encouraging and has created scope for further studies.
Other Science Concepts:
Discover the significance of concepts within the article: �Efficacy of Virechana and Basti Karma with Shamana therapy in the management of essential hypertension: A comparative study�. Further sources in the context of Science might help you critically compare this page with similair documents:
Bastikarman, Treatment modalities, Blood-pressure, Etiological factor, Shamanacikitsa, Inclusion criteria, Exclusion criteria, Clinical trial, Virechana Karma, Randomized clinical trial, Systolic blood pressure, Diastolic blood pressure, Chronic renal failure, Mild Purgation, Criteria for assessment, Overall effect, Essential hypertension, Randomized open clinical trial, Rakta Pradoshaja Vikara, Symptomatology, Ayurvedic parlance, Systolic and diastolic, Prevention and control, Arrhythmia, Patient demographic, Clinical symptom.